Skip to main content

Evans John M.'s Form 4 filing

Beam Therapeutics Inc. (BEAM) · filed May 2, 2022

Accession no.
0000899243-22-016164
Filed
May 2, 2022
Trade date
Apr 28, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 12 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.90M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Evans John M.CIK 0001786304Director, Officer (CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 28, 2022Common StockMOption exerciseAcquired+12,246$7.22+$88,416.121,101,316Direct
Apr 28, 2022Common StockMOption exerciseAcquired+47,204$1.03+$48,620.121,148,520Direct
Apr 28, 2022Common StockSSaleDisposed−3,900$36.59F2−$142,7011,144,620Direct
Apr 28, 2022Common StockSSaleDisposed−13,655$37.48F3−$511,789.41,130,965Direct
Apr 28, 2022Common StockSSaleDisposed−6,842$38.32F4−$262,185.441,124,123Direct
Apr 28, 2022Common StockSSaleDisposed−4,503$39.49F5−$177,823.471,119,620Direct
Apr 28, 2022Common StockSSaleDisposed−1,100$40.73F6−$44,8031,118,520Direct
Apr 28, 2022Common StockSSaleDisposed−6,450$36.98F7−$238,521156,550Indirect
Apr 28, 2022Common StockSSaleDisposed−7,745$37.84F8−$293,070.8148,805Indirect
Apr 28, 2022Common StockSSaleDisposed−3,100$38.75F9−$120,125145,705Indirect
Apr 28, 2022Common StockSSaleDisposed−2,348$39.73F10−$93,286.04143,357Indirect
Apr 28, 2022Common StockSSaleDisposed−357$40.88F11−$14,594.16143,000Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 28, 2022Common StockMOption exerciseDisposed−12,246$0.00$0210,754Direct
Apr 28, 2022Common StockMOption exerciseDisposed−47,204$0.00$0237,141Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $36.36 to $36.97, inclusive.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.06 to $37.86, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $38.09 to $38.67, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $39.21 to $39.88, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.08 to $40.80, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $36.36 to $37.34, inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.38 to $38.37, inclusive.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $38.405 to $39.261, inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $39.51 to $40.32, inclusive.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.70 to $40.96, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)